Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 2.2B | 2.1B | 2.1B | 2.2B |
Cost of revenue | 1.8B | 1.7B | 1.6B | 1.7B |
Gross profit | 420M | 445M | 453M | 502M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 204M | 196M | 171M | 191M |
Other operating expenses | 10M | 16M | 15M | 17M |
Operating income | 206M | 233M | 267M | 294M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 53M | 51M | 53M | 58M |
Other income expense | -14M | -12M | -29M | -17M |
Pretax income | 139M | 170M | 185M | 219M |
Tax provision | 35M | 43M | 47M | 55M |
Net income | 104M | 127M | 138M | 165M |
Basic EPS | 0.4 | 0.4 | 0.5 | 0.6 |
Diluted EPS | 0.3 | 0.4 | 0.5 | 0.6 |
Basic average shares | 301.2M | 302.2M | 301.5M | 301.3M |
Diluted average shares | 301.6M | 303.2M | 302.7M | 302.6M |
EBITDA | 335M | 364M | 403M | 432M |
Net income from continuing op. | 104M | 127M | 138M | 165M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |